Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Dr. Miller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2007 - 2010
Baylor College of MedicineResidency, Internal Medicine, 2004 - 2007- Baylor College of MedicineClass of 2004
Certifications & Licensure
FL State Medical License 2021 - Present
GA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
AZ State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025
OK State Medical License 2023 - 2025
American Board of Internal Medicine Gastroenterology- Join now to see all
Publications & Presentations
PubMed
- 2 citationsImmune Checkpoint Inhibitors Suppress Hepatitis C Virus Replication in Infected Patients With Solid Tumors.Marcel Yibirin, Khalis Mustafayev, Jeff Hosry, Pooja Pundhir, Joseph Klingen
The American Journal of Gastroenterology. 2023-09-01 - 3 citationsSafety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.Mirella Nardo, Bulent Yilmaz, Blessie Elizabeth Nelson, Harrys A Torres, Lan Sun Wang
The Oncologist. 2023-08-03 - Hepatitis B virus reactivation in cancer patients receiving direct-acting antivirals for hepatitis C virus infection.Haley Pritchard, Jessica P. Hwang, Georgios Angelidakis, Marcel Yibirin, Lan Wang
Journal of Viral Hepatitis. 2021-02-01
Journal Articles
- Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational StudyFelipe Samaniego, Boris Blechacz, Ahmed Kaseb, Bruno P Granwehr, Aung Naing, Issam I Raad, Ethan Miller, Harrys A Torres, Nature
Authored Content
- Determinants and Prognostic Value of Quality of Life in Patients with Pancreatic Ductal AdenocarcinomaFebruary 2018
- Determinants and Prognostic Value of Quality of Life in Patients with Pancreatic Ductal AdenocarcinomaFebruary 2018
- Determinants and Prognostic Value of Quality of Life in Patients with Pancreatic Ductal AdenocarcinomaFebruary 2018
Press Mentions
Rare Incidence of ICI-Related Hepatotoxicity Frequently Ends in Treatment DiscontinuationFebruary 12th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
